Journal Logo

You can read the full text of this article if you:

Ovid Member Institutional Access
Original Articles

Exploratory Phase II Trial to Evaluate the Safety and the Antiepileptic Effect of Pitolisant (BF2.649) in Refractory Partial Seizures, Given as Adjunctive Treatment During 3 Months

Collart Dutilleul, Pierre PharmD*; Ryvlin, Philippe MD, PhD; Kahane, Philippe MD, PhD; Vercueil, Laurent MD; Semah, Franck MD§; Biraben, Arnaud MD; Schwartz, Jean-Charles MD, PhD; De Seze, Jérôme MD, PhD*; Hirsch, Edouard MD, PhD#; Collongues, Nicolas MD, PhD*

Author Information
Clinical Neuropharmacology: 7/8 2016 - Volume 39 - Issue 4 - p 188-193
doi: 10.1097/WNF.0000000000000159
  • Buy


Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.